Soon after erythromycin was introduced, strains of Staphylococcus aureus and other species appeared that were resistant to this antibiotic. Erythromycin resistant organisms were also relatively easy to select from sensitive bacterial populations in vitro. These observations resulted in the recommendation that there should be some restriction in the use of erythromycin in order to limit the incidence of resistant bacteria. Also, erythromycin was often used either in short courses or combined with another antibiotic in order to reduce the apparent risk of mutation to resistance (Cruickshank et al., 1973) .
However, two aspects of erythromycin resistance in Staph. aureus posed problems: 1 The mutants selected in vitro were often slowgrowing and unstable, whereas resistant isolates from clinical material generally had normal growth rates and appeared to be fully virulent (Garrod et al., 1973) . 2 The nature of the resistant clinical isolates sometimes differed from the laboratory mutants in that the former could be resistant to erythromycin only (dissociated resistance; see Garrod (1957) and Weaver and Pattee (1964) ) whereas the latter were always resistant to other macrolide antibiotics in addition to erythromycin.
These phenomena suggest that the laboratory manipulations may not always be a true reflection of the occurrence of events in vivo; ie, the explanation for erythromycin resistant bacteria appearing in vivo may not be a succession of mutants as presumably occurs with 'training' methods in vitro.
In this paper the properties of 100 naturally 
PROPERTIES OF ERYTHROMYCIN RESISTANT MUTANTS SELECTED IN VITRO
The 40 mutants were picked off onto nutrient agar, phage typed, and then inoculated into peptone water for MIC determination. All were inhibited by between 5 and 100 ,ug erythromycin/ml and between 25 and 1000 ,ug spiramycin/mI. All were more resistant, by a factor of at least fivefold, to spiramycin than to erythromycin (Table 1) . That some were inhibited by levels as low as 5 ,tg erythromycin/ml was due to instability of the resistance. Sixteen of the 40 isolates showed this after three subcultures, when the population of bacteria comprised a mixture of slow-growing erythromycin resistant colonies (colony diameters 0-5 mm) and normal growing colonies (colony diameter > 2 mm) that were either sensitive (MIC <0 5 ,ug/ml) or only slightly resistant (MIC 0.5-5 ,g/ml).
None of the mutants was resistant to high levels of lincomycin (MIC <1 0 ,tg/ml).
It has been found that pre-incubation of resistant colonies from clinical material in peptone water containing 0-10 ,ug/ml erythromycin is adequate to cause full induction of erythromycin resistance (Weaver and Pattee, 1964) . The mutants were therefore incubated in peptone water containing either 0-02 ,tg or 0-20 ,tg erythromycin/ml before determination of MICs. This treatment did not increase the level of resistance to either erythromycin, lincomycin or spiramycin, ie, the resistance of the mutants was non-inducible.
PROPERTIES OF ERYTHROMYCIN RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS ISOLATED FROM CLINICAL MATERIAL
All the isolates produced normal colonies morphologically and were coagulase and DNAse positive. Sixty-one were obtained from lesions with pus. Single cell MICs were obtained after incubation in peptone water with or without the addition of 0-02 tlg erythromycin/ml.
Three patterns of sensitivity resulted (Table 2) : 1 Inducible resistance to erythromycin in 84 strains In these, the MIC of erythromycin without pre- incubation with the antibiotic varied from 1 to 25 ,ug/ml. After pre-incubation, the MIC was always greater than 1000 ,ug/ml. These strains were sensitive to lincomycin (MIC <1 ,ug/ml) and spiramycin (MIC < 25 ,ug/ml) whether or not the cultures were pre-incubated with erythromycin. On disk testing with lincomycin and erythromycin disks adjacent, all these strains showed 'dissociated' resistance in which the presence of erythromycin appeared to cause resistance to lincomyin (Garrod et al., 1973) . However, by MIC determination erythromycin did not seem to induce lincomycin resistance (see above), so the explanation for this type of zone phenomenon on disk testing is unexplained. However, in other properties these isolates resembled those erythromycin resistant isolates described by Garrod (1957) as possessing dissociated resistance.
2 Constitutive resistance to erythromycin in 10 strains
In these, every cell of a culture was highly resistant to erythromycin (MIC > 1000 ,ug/ml) whether or not it had been pre-incubated with erythromycin. These strains were sensitive to lincomycin and spiramycin even after pre-incubation with erythromycin.
3 Constitutive resistance to erythromycin, lincomycin, and spiramycin in 6 strains In these, every cell was resistant (MIC > 1000 ,ug/ml) to each of these antibiotics whether or not the cultures had been pre-incubated with subinhibitory concentrations of erythromycin.
Discussion
The difficulty with which erythromycin resistant mutants can be selected in vitro was notable. From more than a total of 1014 cells of 20 strains of sensitive staphylococci not a single one-step highlevel (MIC > 50 ,ug/ml) mutant could be obtained. This contrasts markedly with the ease with which one-step mutants resistant to novabiocin, streptomycin, or rifampicin can be selected in vitro (Lacey, 1972) . However, by serial transfer of cultures in media containing increasing levels of antibiotic, colonies resistant to erythromycin could be isolated. The properties of these mutants were similar, namely, the resistant colonies were small and the resistance was unstable. Also, on first isolation the mutants showed resistance to both erythromycin and spiramycin. (Jevons et al., 1966; Lacey, 1975 (Lacey, 1975) .
3 Becuase erythromycin resistance is inducible, a complex mechanism must exist to effect this. It is reasonable to conclude that this has evolved infrequently on the grounds of improbability. It is not surprising that none of the laboratory mutants showed inducibility.
The relevance of these findings for the clinical use of erythromycin may be considerable. If these findings are extended to the clinical situation the risk that a population of staphylococci initially uniformly sensitive will mutate to erythromycin resistance during therapy, however prolonged, appear to be slight. Any mutants that might appear will be expected to be slow-growing and probably nonpathogenic. Thus, in domiciliary patients, there seems to be no reason to withhold deliberately the use of erythromycin for fear of selecting resistance. This argument probably also applies to the use of this antibiotic against other bacteria, eg, Streptococcus pyogenes, Streptococcus pneumoniae, and Haemophilus influenzae that have been less prone to acquire resistance than Staph. aureus. Indeed, it has been impossible to select in one step mutants of any of these bacteria highly resistant to erythromycin (MIC > I100 ,ug/ml).
In hospital environments where erythromycin resistant staphylococci exist there is a risk that the lavish use of erythromycin will select these isolates. However, this argument applies also to the use of other antibiotics, so that the use of erythromycin with care should not be expected to be specifically liable to select resistant bacteria.
